Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Neoplastic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00311558
What this trial is testing

Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma

Who this might be right for
Cancer
The Cleveland Clinic 18
Testing effectiveness (Phase 2)Study completedNCT03128008
What this trial is testing

Locally Advanced NSCLC Hyperfractionated RT

Who this might be right for
Carcinoma, Non Small Cell Lung (NSCLC)
Duke University 10
Large-scale testing (Phase 3)WithdrawnNCT00576225
What this trial is testing

CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL

Who this might be right for
NSCLC
CTI BioPharma
Early research (Phase 1)Study completedNCT04328740
What this trial is testing

Phase 1 Study of Oral TP-1454

Who this might be right for
Advanced Solid TumorAnal Cancer
Sumitomo Pharma America, Inc. 31
Testing effectiveness (Phase 2)Study completedNCT00976768
What this trial is testing

Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin

Who this might be right for
Advanced Gastric Cancer
Asan Medical Center 44
Not applicableStudy completedNCT05424068
What this trial is testing

Rehabilitation for People With Advanced Cancer

Who this might be right for
Advanced Breast CancerAdvanced Colorectal CancerCancer Rehabilitation
University Health Network, Toronto 111
Testing effectiveness (Phase 2)UnknownNCT06092268
What this trial is testing

A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 270
Early research (Phase 1)Study completedNCT01445405
What this trial is testing

Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer

Who this might be right for
Carcinoma, SquamousHead and Neck CancerOral Cancer+2 more
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT05638295
What this trial is testing

Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm
National Cancer Institute (NCI) 105
Testing effectiveness (Phase 2)Looking for participantsNCT07103395
What this trial is testing

A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer (NSCLC)
Sun Yat-sen University 56
Testing effectiveness (Phase 2)WithdrawnNCT05809895
What this trial is testing

Phase II Study Evaluating the Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Chemotherapy as First-line Treatment for Participants With Advanced Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT00452075
What this trial is testing

Erlotinib as First-line Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) for Patients Unfit for Chemotherapy

Who this might be right for
Non Small Cell Lung Cancer
Rigshospitalet, Denmark 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07677475
What this trial is testing

MRG003 Plus Toripalimab Versus Toripalimab as Neoadjuvant Therapy for PD-L1-Positive, Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Dongguan People's Hospital 65
Testing effectiveness (Phase 2)Looking for participantsNCT06634875
What this trial is testing

Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)

Who this might be right for
Colorectal Cancer Metastatic
Buzzard Pharmaceuticals 20
Early research (Phase 1)Study completedNCT02528357
What this trial is testing

GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1)

Who this might be right for
Neoplasms
GlaxoSmithKline 141
Not applicableLooking for participantsNCT06418412
What this trial is testing

A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC

Who this might be right for
Advanced EGFR Exon 20 Insertion Mutated Non-Small Cell Lung Cancer
National Cancer Centre, Singapore 600
Early research (Phase 1)Looking for participantsNCT05856981
What this trial is testing

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultMetastatic Solid TumorRefractory Cancer+4 more
Sairopa B.V. 130
Large-scale testing (Phase 3)Study completedNCT02713867
What this trial is testing

A Dose Frequency Optimization,Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects With Advanced or Metastatic Non-small Cell Lung Cancer Who Received Up to 12 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 Weeks

Who this might be right for
Lung Cancer
Bristol-Myers Squibb 363
Testing effectiveness (Phase 2)Study completedNCT04349267
What this trial is testing

Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Bristol-Myers Squibb 44
Testing effectiveness (Phase 2)Study completedNCT00074087
What this trial is testing

Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides

Who this might be right for
Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC 49
Next Page